LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

Filter results: >>>>
Small Molecule barcode cell_count frac_dead corpse_count cell_count_dead row column agent concentration role timepoint replicate cell_line dead_count fraction_dead cell_count__time0 dead_count__time0 cell_count__ctrl dead_count__ctrl fraction_dead__ctrl increase_fraction_dead GRvalue
Trametinib
180703_BG_12
19386 0.0261 96 413 7 11
Trametinib
0.000332667
treatment
72 3
MCF10A-GM_8
509 0.0256 1387.8 74.9 21564 711.9 0.0318 -0.00621 0.9469
Trametinib
180703_BG_12
19556 0.0249 47 441 12 19
Trametinib
0.000332667
treatment
72 3
MCF10A-GM_9
488 0.0243 1387.8 74.9 21564 711.9 0.0318 -0.00745 0.9512
Vorinostat
180703_BG_12
21761 0.0411 65 833 5 12
Vorinostat
0.033266667
treatment
72 3
MCF10A-GM_7
898 0.0396 1387.8 74.9 21564 711.9 0.0318 0.00783 1.0046
Trametinib
180703_BG_12
2844 0.0338 57 41 6 13
Trametinib
0.099799981
treatment
72 3
MCF10A-GM_7
98 0.0333 1387.8 74.9 21564 711.9 0.0318 0.00151 0.1988
Etoposide
180703_BG_12
19425 0.0259 53 451 4 10
Etoposide
0.033266667
treatment
72 3
MCF10A-GM_8
504 0.0253 1387.8 74.9 21564 711.9 0.0318 -0.00651 0.9479
Dasatinib
180703_BG_12
18428 0.0240 94 350 3 8
Dasatinib
0.033266667
treatment
72 3
MCF10A-GM_7
444 0.0235 1387.8 74.9 21564 711.9 0.0318 -0.00827 0.9221